Lannett gets marketing approval for new doses of Danazol
April 23 |
April 23 (Reuters) - Lannett Co. Inc. (LCI.A) said it received marketing approval for its generic version of sex hormone Danazol in capsules form of 50 mg and 100 mg.
The company had earlier got U.S. Food and Drug Administration approval for a 200 mg version of the product, it said in a statement. (Reporting by Ankur Relia in Bangalore)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters